Neuro-Oncology Brain Tumors Symposium 2020: Best Practices in Patient Care
LIVECMECNEConferences & Symposia

Add to Calendar Neuro-Oncology Brain Tumors Symposium 2020: Best Practices in Patient Care 10/30/2020 7:00:00 AM 10/30/2020 3:15:00 PM America/New_York Virtual false MM/DD/YYYY


Date & Location
Friday, October 30, 2020, 7:00 AM - 3:15 PM, Virtual, Philadelphia, PA

Course Overview
The purpose of this educational activity is to provide a review of new treatment options in neuro-oncology, including surgical techniques, and intraoperative imaging, along with radiation and systemic therapies that have improved patient outcomes. Sessions will feature the latest advances in state-of-the-art care for practicing clinicians treating patients with brain tumors. Cutting-edge topics in precision medicine, including genetic, translational, and clinical research will also be featured. Activity format will provide significant opportunity for interaction with expert faculty and other attendees with the aim of implementing new standards of patient care. Participants will leave with up-to-date, practical information which will have immediate clinical application, as well as technical and scientific background on the current state, and where the latest scientific advances may take the field.

Target Audience
Specialties - CLINICAL CYTOGENETICS AND GENOMICS, CLINICAL GENETICS AND GENOMICS (MD), CLINICAL MOLECULAR GENETICS AND GENOMICS, INTERNAL MEDICINE - Hematology, INTERNAL MEDICINE - Medical Oncology, LABORATORY GENETICS AND GENOMICS, MEDICAL GENETICS AND GENOMICS - Molecular Genetic Pathology, NEUROLOGICAL SURGERY, NUCLEAR MEDICAL PHYSICS, PATHOLOGY - ANATOMIC, PATHOLOGY - CLINICAL, PATHOLOGY - Cytopathology, PATHOLOGY - Neuropathology, PATHOLOGY-ANATOMIC/PATHOLOGY-CLINICAL, PHYSICAL MEDICINE AND REHABILITATION - Hospice and Palliative Medicine, PHYSICAL MEDICINE AND REHABILITATION - Pain Medicine, RADIATION ONCOLOGY, RADIOLOGY - Neuroradiology


Objectives
  1. Implement WHO classification of brain tumors and how molecular profiling affects diagnosis, MRI interpretation, prognosis and therapy of patients with gliomas
  2. List advances in the surgical treatment of brain tumors including the use of fiber tracking (DTI), awake craniotomy, brain mapping, laser thermocoagulation, and fluorescence IGS (image- guided surgery)
  3. Identify the role of immune system to defend against CNS malignancy including the new class of checkpoint inhibitors and the potential use of CAR-T cell therapy
  4. List the benefits and application of proton therapy for low-grade and malignant gliomas
  5. Identify the scientific rationale, practical application, and survival benefit of electric field therapy for malignant brain tumors
  6. Identify the rationale and potential for viral therapies for malignant gliomas
  7. List recent advances in anti-angiogenic therapy in the treatment of gliomas

Registration
For more information and registration, please visit https://www.med.upenn.edu/brain2020/

For more information please contact Hyacen Putmon.

Accreditation
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  
 
Designation of Credit
Physicians: Penn Medicine designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses: This program provides 6.50 contact hours.

Credits
AMA PRA Category 1 Credits™ (6.50 hours), Non-Physician Attendance / Participation (6.50 hours), Nursing Contact Hours (6.50 hours)